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A B S T R A C T
Less information is available on brain integrity in adults with congenital heart disease than on brain changes in
newborns and children with heart defects. Nevertheless, the number of adults with congenital heart disease is
increasing rapidly and it has been shown that adults with congenital heart disease develop dementia almost
twice as frequently as adults in the general population.
In the context of a rapidly growing congenital heart disease population, neuroradiological-oriented in-
vestigations of biomarkers distinctive for vascular damage, brain aging, and possible cognitive impairment is a
crucial challenge. We provide an overview of the existing literature on neuroimaging studies in adults with
congenital heart disease and discuss methodology issues to further investigate this subject. Overall, we aim to
raise awareness of the importance of brain health studies in adults with congenital heart disease given the likely
increasing impact on social and healthcare systems.
1. Background
Congenital heart disease (CHD) affects almost one out of 100 live-
births with similar prevalence around the world (Triedman and
Newburger, 2016). About 90% of patients with complex CHD (i.e. at-
rioventricular septal defect, interrupted or hypoplastic aortic arch,
pulmonary atresia, truncus arteriosus communis, totally anomalous
pulmonary venous drainage, transposition of great arteries, tetralogy of
Fallot and univentricular heart) survive into adulthood thanks to the
advancement of surgical and medical care. As a consequence, there are
now more adults with CHD (ACHD) than children with CHD (Triedman
and Newburger, 2016). Adequate management of this new population
requires comprehensive evaluation of the effect of ACHD on patients'
aging and possible comorbidities as well as on the potential long-term
impact of related treatments (Marelli et al., 2016). Among potential
comorbidities, brain vascular changes may be a direct complication of
CHD. A large retrospective multicentric study (including 23,153 pa-
tients) reported an incidence of cerebrovascular accidents in CHD
subjects up to 100 times higher than that observed in healthy subjects
of comparable age (Hoffmann et al., 2010). A recent Danish population-
based cohort study has reinforced concern over the risk of cere-
brovascular disease in describing a twofold higher risk of developing
dementia of all-types for those with complex CHD (Bagge et al., 2018).
Indeed, the hazard ratio (HR) for early-onset dementia (< 65 years of
age) was 2.6 (95% confidence interval [CI], 1.8–3.8) when considering
all CHD diagnostic groups compared with controls (Bagge et al., 2018).
When statistical correction for comorbidities (acquired cardiovascular
disease and diabetes mellitus) was performed, ACHD still carried a
slightly higher risk for developing dementia than healthy subjects
(HR=1.48, 95% CI (1.11–1.97)). According to the authors, a possible
explanation might center on a multifactorial altered brain reserves, i.e.
decreased tolerance to brain aging changes (Bagge et al., 2018), in
which brain vascular disease is expected to prevail over the effects of
neurodevelopmental abnormalities as patients with CHD get older
(Marelli et al., 2016). In this regard, it is known that patients with CHD
show signs of brain immaturity already at birth and demonstrate poorer
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neurodevelopmental scores later on (Mebius et al., 2017). Infants with
CHD show a low preoperative cerebral blood flow (Licht et al., 2004)
and a high incidence of white matter abnormalities, similar to that
reported in preterm newborns. Both populations suffer from hypoxic-
ischemia injury with possible impaired delivery of energy substrates,
oxidative stress, and pro-inflammatory states, exacerbated in CHD by
the presence of cardiopulmonary bypass (Miller and McQuillen, 2007).
Brain dysmaturation together with genetic and epigenetic alterations
may account for the adverse, albeit heterogeneous, motor and func-
tional outcomes observed in children and adolescents who undergo
repair of complex CHD. In this context, brain MRI studies in these
young patients are intended to discriminate between those deficits re-
sulting from genetic abnormalities, in particular brain development in
fetal life, and postnatal injuries, in particular those associated with
surgical procedures (Marelli et al., 2016).
In adults, early onset of cardiovascular risk factors for brain injury
such as, among others, hypertension, metabolism disorders and dys-
rhythmia, together with an increased incidence for ischemic and he-
morrhagic stroke, may impact the brain and contribute to precocious
neurocognitive decline in ACHD (Lanz et al., 2015; Marelli et al., 2016).
The brain in CHD patients is primed for vulnerability to insults. As the
cardiovascular disease burden shifts from those factors associated with
the heart disease itself to acquired cardiovascular comorbidities, the
decreasing gradient of neurodevelopmental abnormalities is replaced
by an increasing gradient of neurovascular disease (Marelli et al.,
2016).
In spite of the clear association between CHD and acquired vascular
brain changes, in-depth knowledge on the evolution of neurocognitive
functions and correlated imaging biomarkers of brain vascular damage
in ACHD is currently lacking. Herein, we present a summary of litera-
ture reports aimed at investigating this association.
2. Materials and methods
2.1. Search strategy and eligibility criteria
In January 2019, a systematic search was performed using
MEDLINE (PubMed, www.pubmed.gov) for neuroimaging investiga-
tions of adults with congenital heart disease. The search query was:
(brain volume[Title]) OR magnetic resonance imaging of the brain
[title]) OR cortical thickness[Title]) OR cerebral blood flow[Title]) OR
cerebral damage[Title]) OR brain damage[Title]) OR brain aging
[Title]) OR cerebral and pulmonary thrombosis[Title])) AND (tetralogy
of Fallot[Title] OR congenital heart disease[Title])). The search was
limited to original articles published in English in peer-reviewed jour-
nals with an available abstract. Studies on fetuses, newborns, children
and adolescents were excluded. No limits were applied regarding
publication date.
The initial screening of eligible articles was performed, based only
on title and abstract, by two independent readers. Eligible articles were
those that reported in the abstract qualitative or quantitative brain
features obtained through neuroimaging in adult patients with con-
genital heart disease. The full text of all eligible articles was thereafter
evaluated. Finally, the reference lists of the included articles were hand-
searched for additional eligible studies.
2.2. Data extraction
We extracted the journal name, year of publication, study design,
and numbers of patients and controls for each included article. We also
extracted the type of CHD and the demographic details of the patient
group. Moreover, we reported magnetic field strength, MRI protocol
and brain imaging features. We provided descriptive statistics for nu-
merical variables and qualitative descriptions for nominal variables like
MRI protocols and brain features.
3. Results
3.1. General overview
From the initial search, 14 articles were retrieved of which 5 were
eligible for inclusion. One additional article was retrieved from the
reference lists of the 5 selected articles. All six articles had a cross-
sectional design with prospective patient enrollment. The number of
enrolled ACHD subjects ranged from 10 (Codari et al., 2018; Cordina
et al., 2014) to 72 (Jensen et al., 2015) with a median value of 31
subjects and a interquartile range (IQR) of 11–60 subjects. Inclusion
and exclusion criteria for patients' eligibility among the studies were
heterogeneous (Table 1) or even not specified (Jensen et al., 2015).
A control group was absent in three of the six articles (Chai et al.,
2018; Jensen et al., 2015; Sluman et al., 2017). The age of the enrolled
ACHD patients ranged from 18 years (Horigome et al., 2006) to 69 years
(Sluman et al., 2017). However, due to the heterogeneity of the re-
ported results, descriptive statistics were not performed for this vari-
able. Table 1 summarizes the information extracted from the included
studies.
The image modality of choice was always MRI. The magnetic field
strength was 1.5 T in three studies (Codari et al., 2018; Cordina et al.,
2014; Horigome et al., 2006) and 3 T in the remaining studies (Chai
et al., 2018; Jensen et al., 2015; Sluman et al., 2017). Detailed char-
acteristics of the MR sequences used are presented in Table 2.
3.2. Main findings
Horigome et al. reported on 15 ACHD patients that had not un-
dergone cardiopulmonary bypass or catheter interventions. Seven
(47%) patients showed MRI signs of chronic brain infarctions, which
were visible as lesions characterized by low signal intensity on T1-
weighted images and high signal intensity on T2-weighted images.
Three patients also showed diffuse cortical atrophy. One-way ANOVA
revealed statistically significant differences in terms of packed cell vo-
lume (p= .016), protein C activity (p= .002) and oxygen saturation
(p < .001) between healthy subjects and patients. A post-hoc analysis
revealed lower oxygen saturation (77.9% ± 5.8% vs. 88.0% ± 6.6%,
p < .005); higher packed cell volume (63.2% ± 7.6% vs.
54.3% ± 7.3%, p < .05); and reduced protein C activity
Table 2
Magnetic field strength and sequence protocols adopted in studies investigating brain MRI in ACHD patients.
Study Field strength T1-weighted T2-weighted FLAIR MRA T2*-weighted DWI ADC Perfusion
Horigome et al. (2006) 1.5 T ✓ ✓ ✓ ✓ – – – –
Cordina et al. (2014) 1.5 T ✓ – ✓ ✓ ✓ ✓ – –
Jensen et al. (2015) 3 T ✓ ✓ ✓ ✓ ✓ ✓ ✓ –
Sluman et al. (2017) 3 T Protocol not reported
Chai et al. (2018) 3 T ✓ – ✓ – – – – ✓
Codari et al. (2018) 1.5 T ✓ – ✓ – ✓ – – –
Abbreviations: ACHD=adults with congenital heart disease; FLAIR=fluid-attenuated inversion recovery; MRA=magnetic resonance angiography;
DWI= diffusion-weighted imaging; ADC= apparent diffusion coefficient; ASL= arterial spin labeling.
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(65.6% ± 15.9% vs. 88.7% ± 3.4%, p < .05) in patients with brain
MRI abnormalities compared to patients with normal brain MR images
(Horigome et al., 2006).
Cordina et al. evaluated brain MRI features in ACHD patients
without any history of stroke or neurological deficits. Imaging and
blood sampling analysis were performed on ten cyanotic ACHD patients
with unrepaired defects. Aside from generalized global gray and white
matter volume reduction, cortical gray matter was symmetrically
thinned in the dorsolateral prefrontal cortex. The cortical thickness
showed a significant negative correlation with serological biomarkers
of inflammation linked to heart failure such as high sensitivity C-re-
active protein (R=−0.964, p < .0001), endothelial dysfunction
(asymmetric dimethylargine, R=−0.75, p= .026) and neuro-hor-
monal activation (brain natriuretic peptide, R=−0.89, p= .009). No
significant correlation was noted between MRI brain volume measures
and oxygen saturations, packed cell volume and viscosity. In addition,
lacunar infarcts were observed in nine patients. Finally, the white
matter hyperintensities (WMH) burden was also found to be high at
semi-quantitative assessment. Peculiarly, four patients displayed mul-
tiple subtentorial (cerebellar) lacunes (Cordina et al., 2014).
Jensen et al. investigated pulmonary and cerebral thrombosis in
ACHD patients assessed through multimodal imaging. Seventy-two cy-
anotic ACHD patients (40.0 ± 14.0 years) with residual unidirectional
or bidirectional shunts and oxygen saturation (83% ± 7%) underwent
brain MRI. While 34/72 patients showed lacunar and/or cortical signs
of previous stroke, only 7/72 (10%) patients presented with a history of
stroke. The remaining 27 patients were considered to have silent brain
infarcts. A high prevalence of WMH (47/72 patients, 65%) was also
reported (Jensen et al., 2015).
Sluman et al. reported on brain damage in patients with repaired
ACHD. An increased mean volume for discrete foci of WMH was noted
in patients (469mm3 ± 960mm3) than in controls
(188mm3 ± 258mm3 retrieved from a previously published database
(Neema et al., 2009)). Furthermore,a higher frequency of cerebral in-
farcts was observed in 64 patients with Tetralogy of Fallot (age
38.5 ± 10.5 years) that underwent cardiac and brain MRI than in the
general population. The prevalence of cerebral infarcts was 19%
(n=12, seven cortical and five subcortical infarcts). Neuropsycholo-
gical testingrevealed cognitive impairment in 21 patients (32% of the
study sample), mostly affecting areas related to language and executive
functioning (Sluman et al., 2017).
Chai et al. performed quantitative analysis of cerebral blood flow
(CBF) using arterial spin labeling (ASL) in 46 adult patients with re-
paired Tetralogy of Fallot (age 37.4 ± 14.0 years; mean ± SD) (Chai
et al., 2018). WMH was found in 83% (n=30) of 36 subjects on which
assessments were made. Logistic regression analysis revealed sig-
nificant correlations between WMH burden and age at first surgery
(p < .010), body mass index (p < .050) and patient age (p < .05).
Moreover, the year of first surgery and age remained independent
predictors of WMH presence at multivariate analysis (combined
R2=0.44). Regarding cerebral perfusion in different vascular terri-
tories, the difference in CBF between areas of normal appearing white
matter and WMH were only borderline significant (p= .070) (Chai
et al., 2018).
Finally, a proof-of-concept study by Codari et al. investigated early
signs of brain aging in ACHD through the evaluation of imaging signs of
cerebral small vessel disease (cSVD) in 10 adult patients with repaired
Tetralogy of Fallot (median age 45.0 years; range 22–64 years). The
authors noted a high number of cerebral microbleeds (CMBs) in the
patient group (6.0 [4.0–7.8]; median and [IQR]) and no CMBs at all in
an age and sex-matched control group (p= .002). However, no sig-
nificant correlation was found between the presence of CMBs and the
number of surgical interventions with cardiopulmonary bypass
(ρ= 0.384, p= .273) Moreover, a significant positive correlation
(ρ= 0.80, p= .005) was found between WMH burden and New York
Heart Association (NYHA) functional classification (Codari et al.,
2018).
4. Discussion
In 2006, Horigome et al. (Horigome et al., 2006) performed the first
neuroimaging investigation on ACHD. The lower arterial oxygen sa-
turation and higher hematocrit observed in the patient group allowed
the authors to postulate a link between reactive erythrocytosis and
cerebrovascular accidents (Horigome et al., 2006). They suggested that
chronic hypoxemia and a resulting increase in hematocrit may have
caused cerebral infarctions in patients with ACHD with uncorrected
heart disease. An impact on the coagulation system, namely suppression
of the thrombomodulin-protein C-protein S system, was suggested by a
significant reduction in protein C activity in ACHD patients with brain
MRI abnormalities compared with ACHD patients without abnormal
MRI findings. This may have resulted from primary downregulation of
the coagulation system due to chronic vessel injury from hyperviscosity,
hypoxemia, and consumption of coagulation factors and platelets. The
authors noted multiple and scattered subclinical ischemic lesions to
support the abovementioned mechanisms (Horigome et al., 2006).
In 2014 Cordina et al. (Cordina et al., 2014) reported quantitative
measures of brain features in patients with ACHD. Their results re-
vealed focal reduction of the dorsolateral prefrontal cortex, which is
involved in cognitive processes related to executive functions. Ac-
cording to the authors, vascular injury due to inflammation, endothelial
dysfunction, and neuro-hormonal activation was considered to un-
derpin the observed loss of gray matter. In contrast with the previous
report, oxygen saturation and blood viscosity were not correlated with
any of the measures of brain volume.
In 2015, Jensen et al. (Jensen et al., 2015) used multiple imaging
modalities to investigate cerebral and pulmonary thrombosis in patients
with cyanotic congenital heart disease. Complexity of the heart disease
and low oxygen saturation were both found to be significant risk factors
for cerebral infarction. Overall, the study looks at thromboembolism as
a potential pathogenetic mechanism in determining either symptomatic
or subtle brain pathological changes. Specifically, the authors did not
find any statistical significance for the association between hemostatic
imbalance or reactive erythrocytosis and cerebral thrombosis, sug-
gesting that ischemia rather than thromboembolism could underpin the
MRI findings reported. According to the authors, the high number of
brain infarcts located in the subependymal area and the increased WMH
burden support the ischemic-driven argument (Jensen et al., 2015).
Recently, Sluman et al. (Sluman et al., 2017) reported a lower
prevalence of cerebral infarcts in cyanotic ACHD patients than had
previously been described (Horigome et al., 2006; Jensen et al., 2015).
In their studies, brain damage was significantly related to patient age
and age at first surgery, in agreement with the hypothesis that prenatal
and ante-surgical brain injury play a crucial role for subsequent brain
parenchymal integrity. Interestingly, no statistically significant differ-
ence was found in the number of surgeries between patients with ab-
normal MRI findings and those without. Consequently, cardiac surgery
could not be held entirely responsible for the pathological neuroima-
ging findings observed, indicating possibly different, unconsidered
etiologies. Moreover, the observed cognitive impairment mainly af-
fecting language and executive functioning support the imaging find-
ings reported by Cordina et al. (Cordina et al., 2014) involving thinned
cortical thickness of the dorsolateral prefrontal cortex.
Chai et al. emphasized the statistical significance of age at first
surgery as a possible predictor for WMH, supporting the findings of
Sluman et al. (Sluman et al., 2017), concerning the change in surgical
techniques and patient management that occurred during the second
half of the last century (Apitz et al., 2009). As possible pathogenic
explanations for vascular changes in adults with repaired cardiac dis-
ease, the authors took into account perinatal and preoperative cyanosis,
surgical damage and predisposition to chronic cerebral microvascular
disease, namely accelerated vascular aging (Chai et al., 2018).
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In addition to the above mentioned brain features, cerebral micro-
bleeds are biomarkers of cSVD and tend to increase with age (Poels
et al., 2011). Even though a cardiopulmonary bypass constitutes a po-
tential leading cause of CMB occurrence (Kim et al., 2017), Codari et al.
did not observe significant correlations between CMB counts in patients
with Tetralogy of Fallot and the number of surgeries and/or number of
cardiac procedures with cardiopulmonary bypass. According to the
authors, the high CMB burden observed in their patient sample is an
indirect sign of vascular damage and blood brain barrier leakiness in
patients with ACHD (Codari et al., 2018).
Half of the studies investigated vascular brain changes in Tetralogy
of Fallot patients due to their high risk for developing all-cause de-
mentia. Indeed, according to Bagge et al., Tetralogy of Fallot patients
had a hazard ratio for all-type dementia of 2.25 when compared with
the general population, the highest among all CHD groups (Bagge et al.,
2018).
The pathophysiology of the imaging findings reported in the ex-
amined studies constitutes an open issue. Apart from cerebrovascular
damage, the increased cerebral vessel disease burden observed could be
mediated by a combination of genomic vulnerability, brain dysma-
turation, heart surgery and acquired cardiovascular diseases, together
resulting in blood-brain barrier disruption and subsequent MRI-de-
tectable changes (Codari et al., 2018). A disrupted blood-brain barrier
causes extravasation of plasma components and cells, leading to in-
itiation or progression of WMH as well as macrophage and microglia
engulfment with hemosiderin and occurrence of microbleeds (Codari
et al., 2018).
Even though long-term longitudinal data are missing, we may pos-
tulate that the findings observed in adults may not match those seen in
infants undergoing heart surgery. Indeed, white matter injuries in
children have been shown to regress at MRI performed 3months after
cardiac procedures (Beca et al., 2013), while cerebral microbleeds
might evolve or more seldom disappear (Poels et al., 2011). That is to
say, the imaging findings observed constitute the evolving result of a
cumulative burden of biological aging and cerebrovascular damage that
cannot be extensively explained by perinatal injury and heart surgery
alone.
The evaluated studies represent the first attempts at understanding
imaging-based vascular brain sequelae in patients with ACHD. In our
opinion, this topic should be investigated more thoroughly.
Unfortunately, the heterogeneity in terms of study design prevents us
from drawing conclusions. Small samples limit three studies (Codari
et al., 2018; Cordina et al., 2014; Horigome et al., 2006). Moreover,
three others focused on patients with ACHD with uncorrected defects or
residual shunts (Cordina et al., 2014; Horigome et al., 2006; Jensen
et al., 2015), meaning that chronic hypoxemia or paradoxical emboli-
zation could be responsible. Notably, Cordina et al. (Cordina et al.,
2014), Sluman et al. (Sluman et al., 2017), Chai et al. (Chai et al.,
2018), and Codari et al. (Codari et al., 2018), quantified MRI findings of
brain damage whereas Horigome et al. (Horigome et al., 2006) per-
formed only qualitative analysis, while Jensen et al. (Jensen et al.,
2015) merely estimated the prevalence of cerebral lesions. A further
issue is that control groups were lacking (Chai et al., 2018; Jensen et al.,
2015) or were retrieved from previously published datasets (Sluman
et al., 2017). The latter constitutes a relevant source of bias when
dealing with unstandardized procedures for estimation of biomarkers.
Whereas WMH are widely used as imaging biomarkers of cSVD, their
assessment can be biased. Indeed, the lack of standardization of image
acquisition protocols and post-processing, together with scanner tech-
nical differences and the magnitude and scale variability of MRI signal
intensities across different experimental setup, hinders the reproduci-
bility of the segmentation process.
Brain MRI protocols used in ACHD patients mainly focus on mor-
phological imaging. T1-weighted, T2-weighted, fluid-attenuated in-
version recovery, T2*-weighted or susceptibility-weighted, and diffu-
sion-weighted sequences should be performed according to
standardized research protocols (Wardlaw et al., 2013). Nevertheless,
the use of advanced MRI approaches may improve the characterization
of vascular brain changes in ACHD patients, in particular those occur-
ring in normal-appearing white matter (NAWM) of subjects presenting
with WMH.
Several studies on children with CHD employed different MRI se-
quences to assess vascular brain damage beyond morphology. Such
sequences included magnetic resonance spectroscopy, and diffusion and
perfusion imaging (Miller et al., 2007). However, only a few studies
investigated the value of these techniques in ACHD patients (Chai et al.,
2018; Cordina et al., 2014; Horigome et al., 2006).
In adults, neuroimaging should be able to differentiate past global
lesion burden from present chronic ongoing cerebrovascular disease,
and possibly to estimate the risk of future cerebrovascular
accidents.Measures of past global lesion burden (congenital and in-
fancy-acquired vascular insults) should focus on quantitatively asses-
sing malacic lesions (lacunes, small brain infarcts) and CMBs, as well as
volumetry of total gray matter and white matter.
Measures of adult chronic ongoing cerebrovascular disease are
mainly based on gliotic lesions (WMH), and today can rely on micro-
structural parameters offered by diffusion imaging, using classical dif-
fusion tensor imaging parameters (mean diffusivity, fractional aniso-
tropy, radial and axial diffusivity), or even more advanced two-shells
models such as neurite orientation dispersion and density imaging.
Indeed, diffusion tensor imaging and its derived parameters such as
fractional anisotropy and mean diffusivity allow microstructural
changes in the white matter to be evaluated (Maniega et al., 2015;
Wardlaw et al., 2013). Reduced values of the former and increased
values of the latter have been observed in WMH when compared with
normal-appearing white matter (Bastin et al., 2009). On the other hand,
a snapshot of current ongoing perfusional brain status today may be
assessed by measuring absolute cerebral blood flow by ASL. As well
known for large vessels and small vessel disease, cerebrovascular risk
factors, including decreased cardiac output, may cause global or re-
gional perfusional deficit and are likely to predispose brain to future
ischemic lesions.
Finally, diffusion parameters of microstructural damage and perfu-
sion parameters of functional deficit can also be simultaneously ob-
tained by a promising acquisition method, the so-called intravoxel in-
coherent motion imaging technique (Wong et al., 2017).
Moreover, quantitative maps, in addition to those obtained with
diffusion-weighted protocols, may improve white matter characteriza-
tion. Longitudinal relaxation time (T1), a quantitative estimate of brain
water content, may also a useful technique to detect increased water
content in WMH and in the encompassing NAWM (Bastin et al., 2002;
Maniega et al., 2015; Muñoz Maniega et al., 2017). Furthermore, al-
teration in susceptibility may characterize the myelin damage that oc-
curs as the brain ages. Indeed, susceptibility values change with age. In
particular, a recent study reported that white matter susceptibility va-
lues of three major fiber groups (i.e. internal capsule, splenium of
corpus callosum and optic radiation) decrease during brain develop-
ment and maturation, and slightly increases during brain aging (Li
et al., 2014).
Usually, quantitative and qualitative MRI is performed with mul-
tiple scans. Such comprehensive MRI protocols require long acquisition
times, even on the most recent MRI equipment. The introduction of
innovative techniques may enable faster examinations. An example is
provided by the strategically acquired gradient echo (STAGE) protocol,
which provides whole brain qualitative and quantitative MRI data
suitable for the quantification of vascular brain changes with a limited
acquisition time (Chen et al., 2018; Wang et al., 2018).
Future studies should focus on large samples of clinically stable
repaired ACHD subjects to assess quantitatively the vulnerability for
brain damage, trying to avoid confounding variables. It is crucial to
design cross-sectional and longitudinal studies in which imaging and
both neurocognitive and psychological testing are performed at the
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same time points. The strong evidence for a high risk of psychological
and social functioning impairment resulting from longitudinal popula-
tion-based studies in ACHD calls for the investigation of neuroimaging
correlates of those functional parameters (Zomer et al., 2012).
5. Conclusion
To summarize, ACHD patients constitute a young and increasing
population (Engelfriet et al., 2005). Patients come with a marked risk of
cerebrovascular accidents and may have cognitive drawbacks across
their lifespan (Marelli et al., 2016). Since acquired cardiovascular risk
factors may play a prominent role in determining the high propensity
towards developing dementia in ACHD, it would be advisable to strictly
monitor the brain health of these patients with thorough neuroimaging
protocols and, where possible, to prevent and intervene on those factors
possibly responsible for causing cerebrovascular accidents and eventual
cognitive decline. In this sense, future studies should open the way for
predictive models based on the correlation between brain MRI vascular
biomarkers and cognitive functions in this target population, with the
aim of developing tailored preventive strategies to increase their
quality of life. We stress the need for a more comprehensive view on the
implications for the brain, initially via neuroimaging tools. We hope for
a change in the approach to this peculiar category of patients, whose
health goes far beyond heart defect care.
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